Gerco den Hartog
- Infectious Diseases top 5%
- Immunology top 10%
- Molecular Biology
- Surgery
- Epidemiology
- Co-authors
- Lindsay D. ButcherSheila E. CrowePeter B. ErnstFiona van der KlisHuub F. J. SavelkoulRutger M. ScheppR. J. Joost van NeervenA. Lammers
- Topics
- SARS-CoV-2 and COVID-19 Research (26 papers)COVID-19 Clinical Research Studies (13 papers)Respiratory viral infections research (10 papers)
- Partner nations
- NetherlandsUnited StatesJapan
In The Last Decade
Gerco den Hartog
57 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 96
- Infectious Diseases 387
- Immunology 246
- Molecular Biology 219
- Surgery 171
- Epidemiology 140
Countries citing papers authored by Gerco den Hartog
This map shows the geographic impact of Gerco den Hartog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerco den Hartog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerco den Hartog more than expected).
Fields of papers citing papers by Gerco den Hartog
This network shows the impact of papers produced by Gerco den Hartog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerco den Hartog. The network helps show where Gerco den Hartog may publish in the future.
Co-authorship network of co-authors of Gerco den Hartog
This figure shows the co-authorship network connecting the top 25 collaborators of Gerco den Hartog. A scholar is included among the top collaborators of Gerco den Hartog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerco den Hartog. Gerco den Hartog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 19 | |
| 11 | 7 | |
| 12 | 15 | |
| 13 | 25 | |
| 14 | 52 | |
| 15 | 1 | |
| 16 | 10 | |
| 17 | 80 | |
| 18 | 11 | |
| 19 | 31 | |
| 20 | 23 |
About Gerco den Hartog
Gerco den Hartog is a scholar working on Infectious Diseases, Modeling and Simulation and Microbiology, having authored 61 papers that have together received 1.0k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (26 papers), COVID-19 Clinical Research Studies (13 papers) and Respiratory viral infections research (10 papers). The work is most often cited by research in Infectious Diseases (387 citations), Modeling and Simulation (96 citations) and Immunology (246 citations). Gerco den Hartog has collaborated with scholars based in Netherlands, United States and Japan. Frequent co-authors include Lindsay D. Butcher, Sheila E. Crowe, Peter B. Ernst, Fiona van der Klis, Huub F. J. Savelkoul, Rutger M. Schepp, R. J. Joost van Neerven, A. Lammers, H.K. Parmentier and Guy A. M. Berbers. Their work appears in journals such as Nature Communications, Annals of Internal Medicine and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.